Novo Nordisk
Novo Nordisk is a global healthcare company dedicated to driving change to defeat serious chronic diseases. Their work in metabolic liver disease advances treatment options for patients with MASLD/MASH.
These materials are developed independently by industry partners. While they are subject to review for compliance, they are not created by, nor do they represent the views of, the European Association for the Study of the Liver (EASL).
Track Sponsorship
Content from Novo Nordisk
Explore sponsored educational content, event recordings, and resources
Showing 1-6 of 7 results
Relationship between endothelial dysfunction and metabolic dysfunction-associated steatotic liver di
Educational grant support from: Mirum, Novo Nordisk
Kateryna Pivtorak
Relationship between endothelial dysfunction and metabolic dysfunction-associated steatotic liver di
Educational grant support from: Mirum, Novo Nordisk
Kateryna Pivtorak
Impact of hepatitis C eradication with direct-acting antivirals on metabolic and liver-related outco
Educational grant support from: Novo Nordisk
Clelia Asero
Impact of hepatitis C eradication with direct-acting antivirals on metabolic and liver-related outco
Educational grant support from: Novo Nordisk
Clelia Asero
Advances in Liver Cancer Treatment: From Diagnosis to Cure
A comprehensive webinar exploring the latest therapeutic approaches for hepatocellular carcinoma, including immunotherapy combinations and precision medicine strategies.
Educational grant support from: Novo Nordisk
Dr. John Doe, Dr. first name last name
80m
Advances in Liver Cancer Treatment: From Diagnosis to Cure
A comprehensive webinar exploring the latest therapeutic approaches for hepatocellular carcinoma, including immunotherapy combinations and precision medicine strategies.
Educational grant support from: Novo Nordisk
Dr. John Doe, Dr. first name last name
80m
Test Podcast 5
Educational grant support from: Novo Nordisk
4800m
Test Podcast 5
Educational grant support from: Novo Nordisk
4800m
Test Podcast 4
Educational grant support from: Boehringer Ingelheim, Mirum
560m
Test Podcast 4
Educational grant support from: Boehringer Ingelheim, Mirum
560m
Talk Liver to Me: NAFLD and Metabolic Syndrome
Episode 1: Understanding the metabolic liver disease epidemic
Educational grant support from: Mirum
80m
Talk Liver to Me: NAFLD and Metabolic Syndrome
Episode 1: Understanding the metabolic liver disease epidemic
Educational grant support from: Mirum
80m